Advertisement

Topics

Companies Related to "Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults" [Most Relevant Company Matches] - Page: 5 RSS

09:43 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults" found in our extensive corporate database of over 50,000 company records.

Showing "Study Recombinant Modified Process Hepatitis Vaccine Older Adults" Companies 101–125 of 3,200+

Relevant

PaxVax Corporation

PaxVax is a privately held company established in 2007 to develop and commercialize innovative and socially responsible vaccines against infectious diseases. PaxVax has a clinical-stage product portfolio, including a cholera vaccine entering Phase 3 and a pandemic H5N1 influenza vaccine entering Phase 2. The company also has vaccines in development for HIV...


Pevion Biotech Ltd.

Pevion Biotech successfully applies its proprietary virosome-based technology platforms to the development of efficient and safe prophylactic/therapeutic vaccines. Additionally, Pevion Biotech gives access to these platforms (PeviPROTM and PeviTERTM) as well as to the virosome-based drug delivery platform (PeviPHARTM) to third parties. Pevion Biotech is located in Bern, Switzerland and has 21 empl...

XTL Biopharmaceuticals

TL Biopharmaceuticals Ltd. ("XTL") is engaged in the acquisition, development and commercialization of therapeutics for the treatment of neuropathic pain and hepatitis C. XTL is developing Bicifadine, a serotonin and norepinephrine reuptake inhibitor, for the treatment of neuropathic pain. XTL is also developing several novel pre-clinical hepatitis C small molecule inhibitors. XTL also has an acti...


The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

Vaxxas

Vaxxas is a privately-held biotechnology company focused on enhancing the performance of existing and next generation vaccines with its proprietary Nanopatch™ technology platform. Vaxxas’ Nanopatch contains an ultra-high density array of projections – invisible to the naked human eye – that are dry-coated with vaccine. Application of the ...

Geriatric Consultant Resources LLC

GCR provides scientific information on drug therapy and disease management in the elderly such as osteoporosis, late-life psychosis and heart failure. Our Continuing Education workshops for pharmacists cover the top chronic diseases in older adults including management of Alzheimer's dementia, chronic pain, depression, epilepsy, gastrointestinal disorders and hypertension. The Senior Care Resource...

VGTI Florida

VGTI Florida is the Florida-funded expansion of Oregon Health & Science University's highly successful Vaccine and Gene Therapy Institute. Research at the facility will focus on vaccine development with a special focus on vaccines and therapeutics that protect the aging population, which is the most vulnerable to disease.

Seqirus

In an industry first, Seqirus has successfully produced cell-based influenza vaccine at commercial scale using a candidate vaccine virus (CVV) that has been isolated and grown in cells, rather than in eggs.1,2 CVVs are prepared by the World Health Organization (WHO) Global Influenza Surveillance and Response System (GISRS) and associated laboratories, and ...

PaxVax Inc

PaxVax is a privately held company established in 2007 to develop and commercialize innovative vaccines against infectious diseases. PaxVax has a clinical-stage product portfolio, including a cholera vaccine that recently initiated Phase 3 clinical trials and a pandemic H5N1 influenza vaccine entering Phase 2 clinical trials. The company also has vaccines ...

Bio-Bridge Science

Bio-Bridge Science, Inc., a development stage biotechnology company, engages in the commercial development of vaccines for the prevention and treatment of human infectious diseases. The company is currently developing and commercializing HIV-PV Vaccine I to prevent and treat infection by the human immunodeficiency virus (HIV). It develops HIV vaccines for both preventive and therapeutic purposes. ...

Telormedix SA

Telormedix (www.telormedix.com), founded in October 2007, is a biopharmaceutical company focused on targeted immunity and modulation of the innate immune system for treating cancer and autoimmune diseases. The Company’s lead product, TMX-101, recently entered a Phase I/II clinical trial for the treatment of Non-Muscle Invasive Bladder Cancer (NMIBC). ...

i3 Statprobe

Because we're strong in every area, you can outsource an entire study to i3 Statprobe, or outsource, for example, only the statistical programming for a single study. Or you can outsource only the statistical programming for every study. Use us any way you want to, we encourage it. For example, we'll provide a dedicated team of specialists (say, data coordinators or statistical programmers) to wor...

BioVex

BioVex is a three year old private biotech company that is developing a new class of potent vaccines principally to treat and prevent cancer. The Company is headquartered in Oxford, UK. The Company has three technology platforms based on the manipulation of the herpes simplex type one virus. The Company has two vaccine platforms; OncoVEX and ImmunoVEX and a functional genomics platform for gene de...

Chimerix, Inc

Chimerix Inc. is a privately held biotechnology company creating and developing orally available medicines from bioactive molecules. Application of Chimerix's proprietary technology enhances oral availability, stabilizes drug in plasma, and facilitates the delivery of drugs into targeted tissues. Known drugs can be modified to improve dosing parameters, broaden therapeutic applications and decreas...

Tax Point Advisors

Tax Point Advisors (sm), the nation’s premier provider of research and development tax credit studies, comprises a trusted team of former Big4 accountants, business advisers, and staff with extensive industrial/manufacturing/technical industry background providing the highest degree of professional service. We assist CPA’s and their clients in identifying and capturing their maxim...

Probably Relevant

The Salvation Army

The Salvation Army is a faith-based, comprehensive human service organization whose programs help individuals, families and whole communities lead healthier, safer and more productive lives. The Salvation Army is equipped to respond to both acute disasters such as fires and floods as well as the daily, ongoing struggles of the region's less fortunate individuals. With a 130-year record of accompl...

Themis

Themis is developing urgently needed vaccines to prevent death and disability around the world. We lead in the development of a vaccine against chikungunya, a serious debilitating disease with global outbreak potential. Our innovation in vaccine technology has created a powerful platform and a growing pipeline addressing a broad range of infectious disease...

Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. (NASDAQ-PPHM) is a clinical stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection. The Company is advancing three separate clinical programs with its lead product candidates bavituximab and Cotara®. Bavituximab and Cotara are both in Phase II clinical studies for the treatment o...

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

Medeva Plc

Hepatitis B

Geovax Labs

GeoVax is a Biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus - AIDS) and other infectious agents. Our goals include: developing AIDS vaccines for global markets, manufacturing and testing these vaccines under GMP/GLP conditions (FDA guidelines), conducting phase I/II and III human trials for vaccine safety and effectiveness and obtaining r...

Gen-Probe Life Sciences Ltd

Gen-Probe Incorporated (NASDAQ: GPRO) is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) used primarily to diagnose human diseases and screen donated human blood. NATs harness the power of biotechnology to detect diseases more rapidly and/or accurately than older testing methods, and have therefore become one of the fast...

My Possibilities

My Possibilities is a Plano, Texas-based non-profit, charity - 501(c)(3), for adults with disabilities (Autism, Down Syndrome, Aspergers, Prader-Willi, Head Injuries, etc.). Started in June 2008, this organization is the FIRST full day, full year program in Collin County for Texans, who have "aged out" of secondary education. My Possibilities helps s...

Mucosis

Mucosis B.V. is a clinical-stage biotechnology company developing novel vaccines on its proprietary Mimopath® platform technology. The Mimopath® platform is being studied for various routes of administration including those that provide additional protection in the mucosa, the site where over 90% of pathogens enter the human body. Mucosis’s lead...

Tyrogenex

Tyrogenex is developing X-82, as a targeted therapeutic for ophthalmological diseases and solid tumors. Preliminary data from a phase 1/2 pilot study show that X-82 is well tolerated and did not exhibit any dose-limiting toxicity during the study.


More From BioPortfolio on "Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks